Stock Price, News, Quote and Profile of AKILI INC(NASDAQ:AKLI) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AKILI INC

NASDAQ:AKLI (5/8/2024, 7:00:00 PM)

After market: 0.4018 0 (-1.03%)

0.406

0 (-0.29%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryHealth Care Technology

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap31.91M

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. The company is headquartered in Boston, Massachusetts and currently employs 66 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing and commercializing technologies designed to directly target the physiology of the brain. The Company’s software-based medicine is designed to directly target brain function and is delivered through engaging consumer entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain. The Company’s products include EndeavorRx, Selective Stimulus Management Engine (SSME), Body Brain Trainer (BBT) and Spatial Navigation (SNAV) Engine. EndeavorRx product is measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. SSME is specifically engineered to target and activate the systems in the brain that play a key role in attention function.

Company Info

AKILI INC

71 Commercial Street, Mailbox 312

Boston MASSACHUSETTS

P: 16174560597

Employees: 66

Website: https://www.akiliinteractive.com/

AKLI News

8 days ago - ChartmillWhat's going on in today's session

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

9 days ago - ChartmillTuesday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.